Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
292
-
Total 13F shares, excl. options
-
63.8M
-
Shares change
-
+2M
-
Total reported value, excl. options
-
$7.56B
-
Value change
-
+$224M
-
Put/Call ratio
-
0.72
-
Number of buys
-
155
-
Number of sells
-
-137
-
Price
-
$118.57
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q1 2022
342 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q1 2022.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 292 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.8M shares
.
Largest 10 shareholders include Capital World Investors (6.64M shares), BlackRock Inc. (4.66M shares), STIFEL FINANCIAL CORP (3.05M shares), JANUS HENDERSON GROUP PLC (2.71M shares), Capital International Investors (2.68M shares), MARSHALL WACE, LLP (2.4M shares), Allspring Global Investments Holdings, LLC (2.29M shares), ORACLE INVESTMENT MANAGEMENT INC (2.06M shares), STATE STREET CORP (1.66M shares), and EVENTIDE ASSET MANAGEMENT, LLC (1.64M shares).
This table shows the top 292 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.